Pink Sheet Podcast: New Opioid Approval Standards, Drug Pricing Legislation And New Paragraph IV Data
Executive Summary
Our take on the US FDA's new draft guidance on risk/benefit analysis of opioids, a new version of Senate drug pricing legislation and new FDA data on paragraph IV certifications.